IE
RUBY

Israel Englander’s Rubius Therapeutics, Inc RUBY Stock Holding History

Israel Englander’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-55,600
Closed -$306K – 7764
2022
Q1 		$306K Buy
+55,600
New +$353K ﹤0.01% 5521

Other funds holding RUBY

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Israel Englander's RUBY Position: Q1 2023 in Review

Israel Englander sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 169,571 shares — an estimated $29K sold.

Israel Englander first reported a position in RUBY in Q2 2019 and held it in 14 quarters. The position peaked at $2.87M in Q1 2022. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • Israel Englander reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • Israel Englander sold 169,571 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $29K.
  • Israel Englander first reported a position in Rubius Therapeutics, Inc in Q2 2019 and held it in 14 quarters.
  • Israel Englander's Rubius Therapeutics, Inc position peaked at $2.87M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.